Nektar Therapeutics (NKTR)

Nektar Therapeutics (NKTR) 재무 분석

*모든 숫자는 백만 단위입니다.

기간 종료일	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
기간	3개월	3개월	3개월	3개월	3개월
Revenues	6.72%10.13	10.86	21.81	11.79	11.18
	9.67%39.13	35.68	29.71	-	-
Research and Development	9.67%39.13	35.68	29.71	-	-
Other Operating Expenses	7.88%7.10	7.70	6.85	-	-
Costs And Expenses	5.12%52.47	49.92	49.47	43.46	47.41
Depreciation and Amortization	3.31%0.16	0.15	0.19	0.20	0.21
Operating Income/Loss	8.42%-42.34	-39.05	-27.67	-31.67	-36.23
Nonoperating Income/Loss	150.55%2.04	-4.04	-7.04	-3.35	-3.17
Income/Loss From Equity Method Investments	81.77%-0.32	-1.75	-1.35	-0.53	-2.39
Income/Loss From Continuing Operations Before Tax	6.47%-40.30	-43.09	-34.70	-35.02	-39.40
Income Tax Expense/Benefit	96.88%0.00	0.06	0.03	-0.03	-0.19
	9.54%-40.62	-44.90	-36.08	-35.52	-41.59
Attributable To Parent	9.54%-40.62	-44.90	-36.08	-35.52	-41.59
Basic Average Shares	33.63%33.05	24.74	-	18.95	14.09
Diluted Average Shares	33.63%33.05	24.74	-	18.95	14.09
Basic Earnings Per Share	32.42%-1.23	-1.82	-	-1.87	-2.95
Diluted Earnings Per Share	32.42%-1.23	-1.82	-	-1.87	-2.95